ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

EGRX Eagle Pharmaceuticals Inc

4,05
0,00 (0,00%)
Pré-mercado
Última atualização: 10:26:51
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Eagle Pharmaceuticals Inc EGRX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 4,05 10:26:51
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
4,05
mais cotações »

Notícias Recentes

Data Hora Fonte Título
09/02/202407:45PRNUSEagle Pharmaceuticals, Inc. Securities Fraud Class Action..
02/02/202407:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
26/01/202407:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
19/01/202407:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
18/01/202408:50GLOBEEagle Pharmaceuticals Provides Update on Bendamustine..
12/01/202407:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
05/01/202407:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
18/12/202307:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
06/12/202318:05GLOBEEagle Pharmaceuticals to Present Abstract on Post-hoc..
09/11/202309:30GLOBEEagle Delays Third Quarter 2023 Results and Conference Call
08/11/202310:30GLOBEEagle Pharmaceuticals to Host Third Quarter 2023 Financial..
24/10/202309:40GLOBEEagle Pharmaceuticals Granted Patent for PEMFEXY®
23/10/202307:50GLOBEEagle Pharmaceuticals Granted Unique J-Code and Pass-Through..
04/10/202307:50GLOBEEagle Pharmaceuticals Awarded First Prize for Poster to Be..
19/09/202317:05GLOBEEagle Pharmaceuticals to Present at the Cantor Global..
11/09/202307:50GLOBEEagle Pharmaceuticals to Present CAL02 Trial in Progress at..
30/08/202307:50GLOBEEagle Pharmaceuticals to Present BYFAVO® (remimazolam) for..
29/08/202307:50GLOBEEagle Pharmaceuticals Announces Positive Type C Meeting with..
22/08/202317:05GLOBEEagle Pharmaceuticals to Present at Two Upcoming Healthcare..
17/08/202307:50GLOBEEagle Pharmaceuticals Reiterates 2023 Adjusted non-GAAP..
08/08/202307:50GLOBEEagle Pharmaceuticals Reports Second Quarter 2023 Results
01/08/202307:50GLOBEEagle Pharmaceuticals to Host Second Quarter 2023 Financial..
31/07/202307:50GLOBEEagle Pharmaceuticals Raises 2023 Adjusted non-GAAP EPS¹..
24/07/202307:50GLOBEEagle Pharmaceuticals Announces First Patient Randomized in..
15/06/202307:50GLOBEEagle Pharmaceuticals Provides Business Update and..
14/06/202308:39DJNEagle Pharmaceuticals Gets Fast-Track Designation for..
14/06/202307:50GLOBEEagle Pharmaceuticals Receives FDA Qualified Infectious..
02/06/202319:46PRNUSPalo Alto Networks Set to S&P 500; Others to Join S&P MidCap..
11/05/202307:50GLOBEEagle Pharmaceuticals Announces Acceptance of Two Abstracts..
09/05/202307:50GLOBEEagle Pharmaceuticals Reports First Quarter 2023 Results
01/05/202307:50GLOBEEagle Pharmaceuticals Granted Unique J-Code for Byfavo®¹..

Seu Histórico Recente

Delayed Upgrade Clock